Kuyesa Kwatsopano Kwambiri kwa Odwala omwe ali ndi COPD

dNerva® TLD ndi njira ya bronchoscopic yomwe imasokoneza mitsempha ya m'mapapo kuti ichepetse zotsatira zachipatala za neural hyperactivity. Mwamakina ofanana ndi anticholinergics (gulu lalikulu la mankhwala a COPD) omwe amatengedwa tsiku ndi tsiku kuti athetse zizindikiro, njira yanthawi imodzi ya dNerva imatha kuchepetsa chiopsezo chowonjezereka, kusintha zizindikiro, ndi kukhazikika kwa mapapo.

Chithandizo cha 300th dNerva TLD chinachitika mwezi uno. Dr. Gerard Criner, Wapampando ndi Pulofesa, Thoracic Medicine ndi Surgery ku Lewis Katz School of Medicine ku Temple University adachitira odwala 20 mu mayesero a AIRFLOW-3. "Ngati titha kuthandiza odwala kukhazikika kwa zizindikiro zawo za COPD ndikuwachotsa m'chipatala, zomwe zidzapindulitse odwala, osamalira awo, komanso kuchepetsa kulemetsa kwachipatala," adatero. Kuchulukitsa kwa COPD kumayimira pafupifupi magawo awiri mwa atatu a mtengo wonse wa chisamaliro cha COPD, pafupifupi $49B pachaka ku US.

Mwezi uno ukuwonetsanso gawo lofunika kwambiri la chithandizo mu kuyesa kwa AIRFLOW-3. Pulofesa Pallav Shah, Dokotala Wachipatala ku Chelsea & Westminster ndi Royal Brompton Hospitals ku London ndi Pulofesa wa Respiratory Medicine ku Imperial College ndi amene amalembetsa nawo mayesero. Anachita ndondomeko ya 200th AIRFLOW-3 kwa wodwala yemwe ali ndi COPD yochepetsetsa, yolemetsa kwambiri, komanso mbiri ya kuwonjezereka kwa COPD ngakhale kuti ali ndi chithandizo chabwino chamankhwala. "Odwala ambiri a COPD amavutika ndi moyo wabwino chifukwa cha kuchulukirachulukira kwa COPD," adatero. "Mlandu wa AIRFLOW-3 ndi mwayi wosangalatsa wowunika momwe wodwalayo amachitira kamodzi kokha zomwe zingachepetse kuchulukira kwa COPD ndikuthandizira kukhazikika kwachipatala."

Posachedwapa Kampani yapeza ndalama zoonjezera zokwana $50 miliyoni zangongole ndi ndalama zake ku Innovatus Capital Partners, LLC, zomwe zidzagwiritsidwe ntchito pomaliza kuyesa kwa AIRFLOW-3 ndikupeza chivomerezo cha US FDA.